Cutting Edge Glaucoma - Issue 2

MINIATURIZATION IN GLAUCOMA MONITORING AND TREATMENT: A REVIEW OF NEW TECHNOLOGIES THAT REQUIRE... • 57  10. Gupta P, Zhao D, Guallar E, Ko F, Boland MV, Friedman DS. Prevalence of glaucoma in the United States: the 2005–2008 National Health and Nutrition Examination Survey. Investig Ophthalmol Vis Sci. 2016;57:2905–13. 11. Higginbotham EJ, Alexis D. Is newer necessarily better? The evolution of incisional glaucoma surgery over the last 100 years. Am J Ophthalmol. 2018;191:xxv–xxix. https://doi.org/10.1016/j.ajo. 2018.04.009 12. Hoban K, Peden R, MegawR, Halpin P, TathamAJ. 24-Hour contact lens sensormonitoringof intraocular pressure- related profiles in normal-tension glaucoma and rates of disease progression. Ophthalmic Res. 2017;57:208–15. 13. Kapetanakis VV, Chan MP, Foster PJ, Cook DG, Owen CG, Rudnicka AR. Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and metaanalysis. Br J Ophthalmol. 2016;100:86–93. 14. Kim CY, Park KH, Ahn J, et al . Treatment patterns and medication adherence of patients with glaucoma in South Korea. Br J Ophthalmol. 2017;101:801–7. 15. Kim KH, Lee JO, Du J, Sretavan D, Choo H. Realtime in vivo intraocular pressure monitoring using an optomechanical implant and an artificial neural network. IEEE Sens J. 2017;17:7394–404. 16. Koutsonas A, Walter P, Plange N. Self-tonometry with a telemetric intraocular pressure sensor in patients with glaucoma. Klin Monbl Augenheilkd. 2016;233:743–8 (article in German). 17. Koutsonas A, Walter P, Roessler G, Plange N. Longterm follow-up after implantation of a telemetric intraocular pressure sensor in patients with glaucoma: a safety report. Clin Exp Ophthalmol. 2018:46(5):473–9. https://doi. org/10.1111/ceo.13100 18. Leidl MC, Choi CJ, Syed ZA, Melki SA. Intraocular pressure fluctuation and glaucoma progression: what do we know? Br J Ophthalmol. 2014;98:1315–9. 19. Lewis RA, Christie WC, Day DG, Craven ER, Walters T, Bejanian M, Lee SS, Goodkin ML, Zhang J, Whitcup SM, Robinson, Bimatoprost SR Study Group. Bimatoprost sustained-release implants for glaucoma therapy: 6-month results from a phase I/II clinical trial. Am J Ophthalmol. 2017;175:137–47. 20. Long E, Wan P, Zhuo Y. Predicting the real-world future of glaucoma patients? Cautions are required for machine learning. Transl Vis Sci Technol. 2017;6(6):3. https://doi.org/10.1167/tvst.6.6.3 21. Malihi M, Moura Filho ER, Hodge DO, Sit AJ. Longterm trends in glaucoma-related blindness in Olmsted County, Minnesota. Ophthalmology. 2014;121:134–41. 22. Mehari T, Giorgis AT, Shibeshi W. Level of adherence to ocular hypotensive agents and its determinant factors among glaucoma patients in Menelik II Referral Hospital, Ethiopia. BMC Ophthalmol. 2016;2(16):131. https://doi. org/10.1186/s12886016-0316-z 23. Melki S, Todani A, Cherfan G. An implantable intraocular pressure transducer: initial safety outcomes. JAMA Ophthalmol. 2014;132:1221–5. 24. Molaei A, Karamzadeh V, Safi S, Esfandiari H, Dargahi J, Khosravi MA. Upcoming methods and specifications of continuous intraocular pressure monitoring systems for glaucoma. J Ophthalmic Vis Res. 2018;13:66–71. 25. Mozaffarieh M, Flammer J. New insights in the pathogenesis and treatment of normal tension glaucoma. Curr Opin Pharmacol. 2013;13:43–9. 26. Mozaffarieh M, Grieshaber MC, Flammer J. Oxygen and blood flow: players in the pathogenesis of glaucoma. Mol Vis. 2008;14:224–33. 27. Myers JS, Masood I, Hornbeak DM, Belda JI, Auffarth G, Jünemann A, Giamporcaro JE, Martinez-dela-Casa JM, Ahmed IIK, Voskanyan L, Katz LJ. Prospective evaluation of two iStent® trabecular stents, one iStent Supra® suprachoroidal stent, and postoperative prostaglandin in refractory glaucoma: 4-year outcomes. Adv Ther. 2018;35:395–407. 28. Newman-Casey PA, Blachley T, Lee PP, Heisler M, Farris KB, Stein JD. Patterns of glaucoma medication adherence over four years of follow-up. Ophthalmology. 2015;122:2010–21. 29. Newman-Casey PA, Robin AL, Blachley T, Farris K, Heisler M, Resnicow K, Lee PP. The most common barriers to glaucoma medication adherence: a cross-sectional survey. Ophthalmology. 2015;122:1308–16. 30. Okeke CO, Quigley HA, Jampel HD, Ying GS, Plyler RJ, Jiang Y, Friedman DS. Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patients. Ophthalmology. 2009;116:2286–93. 31. Osorio-Alayo V, Pérez-Torregrosa VT, ClementeTomás R, Olate-Pérez Á , Cerdà-Ibáñez M, Gargallo-Benedicto A, Barreiro-Rego A, Duch-Samper A. Efficacy of the SENSIMED Triggerfish® in the postoperative follow-up of PHACO-ExPRESS combined surgery. Arch Soc Esp Oftalmol. 2017;92:372–8. 32. Ozdemir S, Wong TT, Allingham RR, Finkelstein EA. Predicted patient demand for a new delivery system for glaucoma medicine. Medicine (Baltim). 2017;96(15):e6626. https://doi.org/10.1097/md. 0000000000006626 33. Paschalis EI, Cade F, Melki S, Pasquale LR, Dohlman CH, Ciolino JB. Reliable intraocular pressure measurement using automated radio-wave telemetry. Clin Ophthalmol. 2014;8:177–85.